• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

ANI Pharmaceuticals (ANIP)

Common Shares
Sell: $81.93|Buy: $83.65|Change: 1.45 (1.80%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Address

210 Main Street West
Baudette
MN
USA
56623

Telephone

+1 218 6343500

Website

https://www.anipharmaceuticals.com

Sector 

Healthcare

Forecast key dates

NameKey Date
ANI Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-11-06T08:30:00
ANI Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-11-06T00:00:00
ANI Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-08-07T08:30:00
ANI Pharmaceuticals Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
ANI Pharmaceuticals Inc Annual General Meeting for 20262026-05-22T09:00:00
ANI Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-05-08T08:00:00
ANI Pharmaceuticals Inc First Quarter Earnings Results for 20262026-05-08T00:00:00
ANI Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T08:00:00
ANI Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
ANI Pharmaceuticals Inc Annual Report for 20252026-02-27T00:00:00
Piper Sandler 37(th) Annual Healthcare Conference2025-12-02T14:00:00

Previous key dates

NameKey Date
Piper Sandler 37(th) Annual Healthcare Conference2025-12-02T14:00:00
Jefferies Global Healthcare Conference2025-11-18T10:00:00
ANI Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-07T08:30:00
ANI Pharmaceuticals Inc Third Quarter Earnings Result for 20252025-11-07T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T13:50:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-08T09:00:00
ANI Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-08T08:30:00
ANI Pharmaceuticals Inc Second Quarter Earnings Result for 20252025-08-08T00:00:00
2025 Jefferies Global Healthcare Conference2025-06-04T14:35:00
ANI Pharmaceuticals Inc Annual General Meeting for 20252025-05-22T09:00:00
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ2025-05-20T13:30:00
ANI Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-09T08:00:00
ANI Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-09T00:00:00
2025 RBC Capital Markets Ophthalmology Virtual Conference2025-04-03T07:45:00
Leerink Partners Global Healthcare ConferenceTuesday2025-03-11T15:40:00
Raymond James & Associates' 46th Annual Institutional Investors Conference2025-03-04T13:40:00
ANI Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242025-02-28T08:00:00
ANI Pharmaceuticals Inc Fourth Quarter Earnings Result for 20242025-02-28T00:00:00
ANI Pharmaceuticals Inc Annual Report for 20242025-02-28T00:00:00
Guggenheim Biotech Conference2025-02-05T14:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-14T14:15:00
36th Annual Piper Sandler Healthcare Conference2024-12-04T15:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.